Alimera Sciences Inc

Ownership Transactions Reported by 24 Insiders

Symbol
ALIM on Nasdaq
Industry
Pharmaceutical Preparations
Location
6310 Town Square, Suite 400, Alpharetta, GA

There are no Buy or Sell transactions made by insiders since 10/5/2023

Alimera Sciences Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Velan Capital Investment Management LP 10%+ Owner $6.41M May 17, 2023
Morgan Stanley 10%+ Owner $2.15M Feb 8, 2022
Jason Werner Chief Operating Officer $862K Sep 16, 2024
Russell Skibsted Chief Financial Officer & SVP $292K Nov 21, 2023
John Philip Jones Chief Financial Officer $124K Oct 31, 2022
Peter J. Pizzo III Director $0 Sep 16, 2024
David Holland Chief Marketing Officer & SVP $0 Sep 16, 2024
Philip Ashman President of Int'l Operations $0 Sep 16, 2024
Elliot Maltz Chief Financial Officer $0 Sep 16, 2024
Todd Wood President of U.S. Operations $0 Sep 16, 2024
Adam Morgan Director, 10%+ Owner $0 Sep 16, 2024
Richard S. Eiswirth Jr President and CEO $0 Sep 16, 2024
John Snisarenko Director $0 Sep 16, 2024
Caligan Partners LP 10%+ Owner $0 Sep 16, 2024
Ross D. DeMont Director Sep 16, 2024
Erin Parsons Director Sep 16, 2024
Margaret Pax Director Sep 16, 2024
James R. Largent Director Jan 4, 2023
C. Daniel Myers Chairman Emeritus Aug 1, 2023
Brian K. Halak Director Jan 4, 2023
Roger Sawhney Director Feb 25, 2023
Michael Kaseta Director Sep 16, 2024
Palo Alto Investors LP 10%+ Owner Mar 24, 2023
Garheng Kong Director Jan 4, 2023

Recent Insider Transactions by Companies or Individuals for Alimera Sciences Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.